908 Devices Q2 Earnings Call Highlights

1 hour ago 2

MarketBeat

Tue, August 11, 2026 astatine 10:05 AM CDT 7 min read

Key Points

Interested successful 908 Devices Inc.? Here are 5 stocks we similar better.
Second-quarter gross roseate 23% to $16.1 million, driven by U.S. authorities and section authorities demand, FTIR shipments and the NIRLab acquisition. The institution shipped 198 devices, expanding its installed basal to 4,101.
Profitability improved, with gross borderline expanding to 52% and adjusted EBITDA nonaccomplishment narrowing by much than fractional to $1.9 million. 908 Devices ended the 4th with $101.5 cardinal successful currency and marketable securities and nary debt.
The institution raised its 2026 gross outlook to $68 million-$70 cardinal and expects a precocious won $6 cardinal ProtectIR order to lend successful the 2nd half. Potential upside from the U.S. military's AVCAD programme remains excluded from guidance due to the fact that its timing is uncertain.

908 Devices (NASDAQ:MASS) reported second-quarter gross maturation of 23% arsenic request from U.S. authorities and section authorities customers, FTIR merchandise shipments and its precocious acquired NIRLab level supported results. The institution besides raised the debased extremity of its full-year gross outlook portion continuing to exclude imaginable gross from the U.S. military's AVCAD programme from its halfway guidance.

Revenue for the 4th ended June 30 totaled $16.1 million, up from $13.0 cardinal a twelvemonth earlier. Handheld merchandise and work gross accrued 24% to $15.5 million, driven chiefly by FTIR products, including much than 35 VipIR shipments, and NIRLab law-enforcement revenue. The institution shipped 198 devices during the quarter, bringing its installed basal to 4,101 devices.

→ SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat

Chief Executive Officer and Co-Founder Kevin Knopp said U.S. authorities and section customers accounted for much than fractional of quarterly revenue. He attributed request to continued backing enactment for modernizing detection capabilities amid concerns astir fentanyl, synthetic drugs and chemic hazards.

Margins Improve arsenic EBITDA Loss Narrows

Gross nett roseate to $8.3 cardinal from $6.4 cardinal successful the prior-year quarter, portion gross borderline accrued to 52% from 49%. Adjusted gross borderline was 57%, up astir 85 ground points twelvemonth implicit year.

→ Take-Two's Q1 Results Leave GTA 6 Bulls Stuck successful the Fog of War

Chief Financial Officer Joe Griffith said the borderline betterment reflected higher merchandise revenue, little installation costs pursuing the company's 2025 Boston installation determination and a transmission premix displacement toward U.S. authorities and section placements, which transportation little transmission costs than planetary placements. Those benefits were partially offset by little work gross borderline associated with reduced wide spectrometry work revenue.

Read Entire Article